Fda Approves News Today

The U.S. Food and Drug Administration approved Pivya (pivmecillinam) tablets for the treatment of female adults with uncomplicated urinary tract infections (UTIs) caused by susceptible isolates of Escherichia coli, Proteus mirabilis and Staphylococcus saprophyticus.

The U.S. Food and Drug Administration has approved Basilea Pharmaceutica International Ltd.'s new Zevtera Antibiotic (ceftobiprole medocaril sodium for injection) for three different bacterial infections.

The U.S. Food and Drug Administration granted de novo marketing authorization for Invitae's Common Hereditary Cancers Panel, an in vitro diagnostic test to help detect dozens of cancer types.

FDA Approves New Oncology Drug for Clinical Trials

The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.

The US Food and Drug Administration has approved the medication zuranolone for the treatment of postpartum depression.

The U.S. Food and Drug Administration approved Harm Reduction Therapeutics' RiVive, 3 milligram naloxone hydrochloride nasal spray for over-the-counter or OTC, nonprescription use for the emergency treatment of known or suspected opioid overdose.

Sanofi's RSV antibody shot, nirsevimab, got FDA approval to protect infants on Monday.

Sanofi's RSV antibody shot, nirsevimab, got FDA approval to protect infants on Monday.

The U.S. Food and Drug Administration approved Pfizer Inc's COVID-19 oral antiviral pill Paxlovid for the treatment of mild-to-moderate COVID-19 in adults. Paxlovid is the first oral treatment, and the fourth drug, approved by the agency to treat COVID-19 in adults.